ScholarIQanswers from OpenAlex & ORCID
Daniel Weintraub
ResearcherPublications, citations & collaboration network
Daniel Weintraub is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel Weintraub have?
ScholarIQindexed works
Daniel Weintraub has 624 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel Weintraub have?
ScholarIQcitation count
Daniel Weintraub has 55,470 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel Weintraub?
ScholarIQh-index
Daniel Weintraub has an h-index of 116 in OpenAlex.
What is the i10-index of Daniel Weintraub?
ScholarIQi10-index
Daniel Weintraub has an i10-index of 357 in OpenAlex.
What is the ORCID of Daniel Weintraub?
ScholarIQorcid
The ORCID for Daniel Weintraub is on the source record.
What is the OpenAlex record for Daniel Weintraub?
ScholarIQopenalex
The OpenAlex for Daniel Weintraub is on the source record.
What are the most-cited papers on Daniel Weintraub?
ScholarIQmost cited works
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines
Irene Litvan, Jennifer G. Goldman, Alexander I. Tröster, Ben Schmand, Daniel Weintraub, Ronald C. Petersen, Brit Mollenhauer, Charles H. Adler, Karen Marder, Caroline H. Williams‐Gray, Dag Aarsland, Jaime Kulisevsky, María Rodríguez‐Oroz, David J. Burn, Roger A. Barker, Murat Emre
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
Lon S. Schneider, Pierre N. Tariot, Karen Dagerman, Sonia M. Davis, John Hsiao, M. Saleem Ismail, Barry D. Lebowitz, Constantine G. Lyketsos, J. Michael Ryan, T. Scott Stroup, David L. Sultzer, Daniel Weintraub, Jeffrey A. Lieberman
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
José Á. Obeso, María Stamelou, Christopher G. Goetz, Werner Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bézard, Serge Przedborski, Stéphane Lehéricy, David J. Brooks, John C. Rothwell, Mark Hallett, Mahlon R. DeLong, Connie Marras, Caroline M. Tanner, G. Webster Ross, J. William Langston, Christine Klein, Vincenzo Bonifati, Joseph Jankovic, Andrés M. Lozano, Günther Deuschl, Hagai Bergman, Eduardo Tolosa, Mayela Rodríguez‐Violante, Stanley Fahn, Ronald B. Postuma, Daniela Berg, Kenneth Marek, David G. Standaert, D. James Surmeier, C. Warren Olanow, Jeffrey H. Kordower, Paolo Calabresi, Anthony H.V. Schapira, A. Jon Stoessl
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnović, Seung Ho Choi, Ryan Kurth, Chelsea Caspell‐Garcia, Christopher S. Coffey, Mark Frasier, Luís M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Tanya Simuni, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, the Parkinson's Progression Markers Initiative